Usefulness of N-Terminal Pro–B-Type Natriuretic Peptide Increase as a Marker for Cardiac Arrhythmia in Patients With Syncope
- 1 January 2014
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 113 (1) , 98-102
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The ROSE (Risk Stratification of Syncope in the Emergency Department) StudyJACC, 2010
- NT-pro-BNP for differential diagnosis in patients with syncopeInternational Journal of Cardiology, 2009
- Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)European Heart Journal, 2009
- Natriuretic peptides and troponins in pulmonary embolism: a meta-analysisThorax, 2009
- Role of brain natriuretic peptide (BNP) in risk stratification of adult syncopeEmergency Medicine Journal, 2007
- Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of resultsAmerican Heart Journal, 2006
- N-Terminal Pro–B-Type Natriuretic Peptide Levels for Dynamic Risk Stratification of Patients With Acute Coronary SyndromesCirculation, 2004
- Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillationThe American Journal of Cardiology, 2004
- Implantable Cardioverter–DefibrillatorsNew England Journal of Medicine, 2003
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002